Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1128/AAC.00483-20 http://scihub22266oqcxt.onion/10.1128/AAC.00483-20 32205349!7269512!32205349     free     free     free Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32205349.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Antimicrob+Agents+Chemother 2020 ; 64 (6): ä Nephropedia Template TP {{tp|p=32205349|t=2020. Updated Approaches against SARS-CoV-2 |pdf=|usr=}}{{32205349}} gab.com Text Updated Approaches against SARS-CoV-2 JO: Antimicrob Agents Chemother http://www.kidney.de/pget.php?&tw=1&pmid=32205349 #FOAvip Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lies behind the ongoing outbreak of coronavirus disease 2019 (COVID-19). There is a growing understanding of SARS-CoV-2 in virology, epidemiology, and clinical management strategies. However, no anti-SARS-CoV-2 drug or vaccine has been officially approved due to the absence of adequate evidence. Scientists are racing to develop a treatment for COVID-19. Recent studies have revealed many attractive therapeutic options, even if some of them remain to be further confirmed in rigorous preclinical models and clinical trials. In this minireview, we aim to summarize the updated potential approaches against SARS-CoV-2. We emphasize that further efforts are warranted to develop the safest and most effective approach. Twit Text FOAVip Updated Approaches against SARS-CoV-2 ????Antimicrob Agents Chemother http://www.kidney.de/pget.php?&tw=1&pmid=32205349 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32205349 #FOAvip English Wikipedia <ref>{{Cite pmid|32205349}}</ref> Updated Approaches against SARS-CoV-2 #MMPMID32205349 Li H; Zhou Y; Zhang M; Wang H; Zhao Q; Liu J Antimicrob Agents Chemother 2020[May]; 64 (6): ä PMID32205349show ga Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lies behind the ongoing outbreak of coronavirus disease 2019 (COVID-19). There is a growing understanding of SARS-CoV-2 in virology, epidemiology, and clinical management strategies. However, no anti-SARS-CoV-2 drug or vaccine has been officially approved due to the absence of adequate evidence. Scientists are racing to develop a treatment for COVID-19. Recent studies have revealed many attractive therapeutic options, even if some of them remain to be further confirmed in rigorous preclinical models and clinical trials. In this minireview, we aim to summarize the updated potential approaches against SARS-CoV-2. We emphasize that further efforts are warranted to develop the safest and most effective approach. |*Betacoronavirus[MESH] |COVID-19[MESH] |Coronavirus Infections/immunology/prevention & control/*therapy[MESH] |Humans[MESH] |Inflammation/prevention & control[MESH] |Medicine, Chinese Traditional[MESH] |Pandemics/prevention & control[MESH] |Pneumonia, Viral/immunology/prevention & control/*therapy[MESH] |SARS-CoV-2[MESH] |Virus Internalization[MESH]Updated Approaches against SARS-CoV-2 (epmc).pdf DeepDyve Pubget Overpricing